Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
16.41
-0.36 (-2.15%)
At close: May 23, 2025, 3:59 PM
16.40
-0.06%
After-hours: May 23, 2025, 04:04 PM EDT
Enliven Therapeutics Revenue
Enliven Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Enliven Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
62
Market Cap
805.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|